Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Downgrades Globus Medical to Hold

Needham analyst David Saxon downgrades Globus Medical (NYSE:GMED) from Buy to Hold.
byBenzinga Newsdesk
February 10, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Needham analyst David Saxon downgrades Globus Medical (NYSE:GMED) from Buy to Hold.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Markets Turn More Bullish As Fed Minutes Signal Slower Interest Rate Hikes

By Lisa Levin
November 25, 6:43 AM
The CNN Money Fear and Greed index showed an improvement in overall market sentiment after US stocks closed higher for second straight day. Minutes from the Fed’s meeting indicated that the central bank is looking to slow the pace of interest rate increases. Earlier in November, the Fed raised rates by 75 bps for fourth time in a row.

LITB

Read More

Parker-Hannifin’s Healthy Outlook, Increased M&A Appetite Makes It Attractive, Says Analyst

By Shivani Kumaresan
May 28, 1:40 PM
Mizuho Securities USA analyst Brett Linzey upgraded Parker-Hannifin to Buy, raising the price target from $550 to $650. The upgrade follows the company's five-year financial targets, including 4%-6% organic sales growth CAGR through 2029 and a 27% adjusted operating margin. Linzey highlighted PH's strong execution and credible track record, noting significant growth potential in Aerospace & Defense and clean technology trends.

PH